Emerging Technological Trends and Advancements in Respiratory Medicine
Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases, Page: 591-608
2022
- 1Citations
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Pulmonology is a medical discipline concerned with a number of respiratory diseases also known as “respiratory medicine” or “chest medicine.” Respiratory medicine mainly deals with the diagnosis, management of a wide variety of lung conditions, their linings, blood vessels, muscles, and nerves used to respire. Medicines are the most effective and viable manner for treating respiratory conditions, whether they are inhaled (steroids) or orally or orally administered (antibiotics). A typical example is the use of inhalers in treating allergic lung disorders such as asthma or chronic pulmonary obstructive disease. Also, oxygen therapy with ventilator support is used during adverse respiratory situations like emphysema and idiopathic pulmonary fibrosis. Over the past 20 years, our conceptual understanding about the dynamics of respiratory disorders has changed due to clinical and molecular technological advancements. In light of this rapid growth, this chapter will highlight some of the recent advances in the clinical practice of respiratory medicine. Advancements in the fields of drug developments, biomarker technology, intervention medicine, imaging technology, and nanotechnology have paved the way for treating complicated lung diseases and lung disorders.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85166104961&origin=inward; http://dx.doi.org/10.1007/978-981-16-4392-7_25; https://link.springer.com/10.1007/978-981-16-4392-7_25; https://dx.doi.org/10.1007/978-981-16-4392-7_25; https://link.springer.com/chapter/10.1007/978-981-16-4392-7_25
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know